GLP + GIP (Tirzepatide)
(Weekly Injection)
One of the strongest weight‑loss momentum for many adults—dual‑action GLP‑1/GIP with a simple, once‑weekly routine.
What it is
GLP + GIP (Tirzepatide) (brand names Mounjaro and Zepbound) offers significant health benefits primarily in managing type 2 diabetes and promoting substantial weight loss. Its dual-action mechanism as a GIP and GLP-1 receptor agonist also contributes to several related cardiometabolic improvements.
Who it’s for
Adults who want a potent weekly option and a straightforward plan.
U.S.-Licensed Providers
503A Pharmacy Approved
HIPAA Compliant
Free Discreet Shipping
3-Month Plan
Save $300
$149/mo
$249
$447 for your first 3 months if prescribed.
Prefer monthly?
1-Month Plan · $249/mo
Both include provider evaluation, free discreet shipping, unlimited provider messaging, ongoing dose adjustments, and no membership fee.
4.9
from 2,400+ patients
LegitScript-certified
Licensed in all 50 states
Why customers choose GLP + GIP (Tirzepatide)
Big moves on the scale
Landmark trials show substantial average loss vs placebo; head‑to‑head data favored tirzepatide over semaglutide.
Cravings dialed down
Earlier fullness, fewer snack impulses, easier “no thanks.”*
Weekly rhythm, done right
Clinician‑guided titration and portal check‑ins keep it smooth.
Cash‑pay, no surprises
Clear pricing and refill control.
What GLP + GIP (Tirzepatide)is approved to do
Each of these applies to a specific group. A clinician confirms whether any of them describes you.
Significant Weight Loss
Subtitle
In clinical trials, adults with obesity using tirzepatide lost an average of 15% to over 20% of their initial body weight over 72 weeks, significantly more than with diet and exercise alone or other medications like semaglutide. This is primarily driven by reduced appetite, slowed gastric emptying, and enhanced metabolism.
Improved Glycemic Control
Subtitle
Tirzepatide is FDA-approved for managing type 2 diabetes and has been shown to lower HbA1c levels (a measure of long-term blood sugar) more effectively than other diabetes medications, including insulin and semaglutide.
Treatment of Obstructive Sleep Apnea (OSA)
Subtitle
Tirzepatide (Zepbound brand) is also FDA-approved for treating moderate to severe OSA in adults with obesity, by lowering the number of breathing disruptions during sleep and reducing body weight.
Three steps, and most of it happens on your phone
Most programs make you wait weeks between labs, review and shipping. We compress the whole thing into a single week.
01 — INTAKE
2-Minute Online Assessment
Tell us about your symptoms and health history. No lab work required to begin.
02 — REVIEW
A U.S.-licensed provider reviews
Your provider reviews your health history and determines whether treatment is appropriate — labs only if your provider needs them.
03 — DELIVERY
Ships Free and Discreet
If prescribed, your medication ships to your door in days, in plain packaging.
How we compare
Every number below is what each program advertises publicly — the entry price first, then what that price actually covers.
| Name | Details |
|---|---|
| Ascend Vitality | Starting at $249/mo → As low as $149/mo with 3-month plan. |
| RO Body | $45 first month, then $145/mo membership; medication cost not included (cash‑pay GLP‑1s start $349/mo) |
| Hims | GLP‑1 plans advertised from $199/mo with 6‑month prepay; non‑GLP‑1 oral kits from $69/mo (10‑month prepay). |
| Fridays | “One transparent monthly price” with coaching included (site lists all‑in monthly pricing structure). |
| Eden | GLP‑1s advertised “$139 first month, then $239/mo” on select plans. |
| Ruiget | Promotes non‑GLP‑1 oral combos for weight vs. GLP‑1 injections. (Membership options from $99/mo noted in support article.) |
Additional Health Improvements
Beyond its primary approved uses, ongoing research is exploring other potential benefits:
Cardiovascular Health
Tirzepatide has shown promising results in reducing cardiovascular risk factors. Studies indicate it can lower blood pressure and cholesterol levels, and research from the SUMMIT trial shows it reduces the risk of cardiovascular death or worsening heart failure in patients with obesity and a specific type of heart failure (HFpEF).
Improved Lipid Profile
It helps improve cholesterol profiles by reducing total cholesterol, LDL ("bad") cholesterol, and triglycerides, while increasing HDL ("good") cholesterol levels.
Reduced Inflammation
The medication has demonstrated anti-inflammatory properties, lowering key inflammatory markers associated with chronic diseases, which may contribute to its broad metabolic benefits.
Better Metabolic Health and Body Composition
Beyond weight on the scale, tirzepatide reduces visceral fat (dangerous belly fat around organs) and can improve insulin sensitivity, helping the body process sugar more efficiently.
Potential for Other Conditions
Ongoing research is exploring its use in treating other conditions linked to obesity and inflammation, such as metabolic dysfunction-associated steatohepatitis (MASH, a type of fatty liver disease), polycystic ovary syndrome (PCOS), and even certain neuroprotective effects.
Answers, upfront.
Straight answers on how Ascend Vitality works, what’s included, and what to expect after checkout.
*Results vary; your plan is individualized.
Does it work?
In SURMOUNT‑1 (72 weeks), GLP + GIP (Tirzepatide) produced substantial average weight loss.
Better than Semaglutide?
In a direct comparison, GLP + GIP (Tirzepatide) achieved greater average loss.
*Results vary; your plan is individualized.